Sign inJoin waitlistJoin the waitlist

RD

Ronald Drengler

Physician · Methodist Hospital

Credentials: · ·

History

Methodist Hospital
Present

University of Texas Health Science Center at San Antonio
1991–1993
Internal Medicine
University of Texas Health Science Center at San Antonio
1988–1991
UNIV NACIONAL DE ASUNCION, ASUNCION
1984–1988

Research

Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
Clinical Cancer Research · 2015 · 699 citations
Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP
Journal of Clinical Oncology · 1998 · 124 citations
Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors
Journal of Clinical Oncology · 1999 · First of 15 authors · 89 citations

DH
Daniel Von Hoff
16 papers
MV
Miguel Villalona-Calero
13 papers
ER
Eric Rowinsky
10 papers
Gail Eckhardt
10 papers
LS
Lon Smith
6 papers
GW
Geoffrey Weiss
5 papers
GR
Gladys Rodriguez
5 papers
JE
John Eckardt
5 papers
HB
Howard Burris
4 papers
AG
Allison Garner
3 papers
GG
Giby George
3 papers · 2 as a fellow
Mace Rothenberg
3 papers

Clinical trials

Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors
Study chair · Completed · Phase 1
The University of Texas Health Science Center at San Antonio
1998–2001